As Natco Ups The Ante Lilly Readies Voluntary Licensing For Olumiant

 
• By Anju Ghangurde

Eli Lilly responds with baricitinib donation plan and efforts to sew up royalty free voluntary licenses with local Indian firms as challenger Natco seeks a compulsory license for its version of the JAK inhibitor, which it is ready to launch.

Natco Spurs Licensing Action For Baricitinib? • Source: Alamy

More from Business

More from Scrip